Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
Babcock MC, Mikulka CR, Wang B, Chandriani S, Chandra S, Xu Y, Webster K, Feng Y, Nelvagal HR, Giaramita A, Yip BK, Lo M, Jiang X, Chao Q, Woloszynek JC, Shen Y, Bhagwat S, Sands MS, Crawford BE.
Babcock MC, et al.
Sci Rep. 2021 Jul 14;11(1):14486. doi: 10.1038/s41598-021-93601-1.
Sci Rep. 2021.
PMID: 34262084
Free PMC article.